HAMP and metabolic dysfunction-associated steatotic liver disease: Still, hepcidin/ferritin ratio is significantly lower in HH compared to NAFLD and DIOS (Ravasi et al. 2012), which means that this ratio can differentiate between HH patients and NAFLD/DIOS patients with lower hepcidin/ferritin ratios.